Skip to main content
. 2015 Jun 15;33(21):2353–2360. doi: 10.1200/JCO.2015.60.9271

Fig 6.

Fig 6.

Smoothed average hazard rate for breast cancer recurrence estimated by Kernel estimator according to breast cancer subtype in presence or absence of obesity. HER2, human epidermal growth factor receptor 2; HER2+, HER2-overexpressing breast cancer; HR+, hormone receptor–positive, HER2–nonoverexpressing breast cancer; TN, triple-negative breast cancer.